Literature DB >> 3767125

Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men.

I Annesi, F Kauffmann.   

Abstract

The relation of chronic air-flow limitation and respiratory mucus hypersecretion to all causes of mortality was studied in a population of 1,061 men working in the Paris area, surveyed initially in 1960/1961, and followed for 22 yr. During this period, 369 deaths occurred; VC, FEV1, FEV1/H3, and FEV1/VC were significantly associated with mortality, even when age, smoking, occupational dust exposure, and chronic phlegm were taken into account. Besides the obstructive disorder, the hypersecretory disorder (chronic phlegm) was significantly associated with mortality. Controlling, using Cox's model, for age, FEV1/H3, smoking habits, and dust exposure, all factors associated with chronic mucus hypersecretion and mortality, showed that phlegm production remained significantly related to death (relative risk, = 1.35; p less than 0.01). Although relatively weak, this relationship is not negligible in terms of public health because of the high prevalence of chronic phlegm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767125     DOI: 10.1164/arrd.1986.134.4.688

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  22 in total

Review 1.  Airway hyperresponsiveness and COPD mortality.

Authors:  J Vestbo; E F Hansen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?

Authors:  M J Thomason; D P Strachan
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

3.  Ventilatory function, height, and mortality among lifelong non-smokers.

Authors:  D P Strachan
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

4.  Relations between occupation, smoking, lung function, and incidence and mortality of chronic non-specific lung disease: the Zutphen Study.

Authors:  D Heederik; H Kromhout; D Kromhout; J Burema; K Biersteker
Journal:  Br J Ind Med       Date:  1992-05

5.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

6.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.

Authors:  P Lange; J Nyboe; M Appleyard; G Jensen; P Schnohr
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

Review 7.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

Review 8.  Nimesulide in the treatment of chronic bronchitis.

Authors:  M Sofia; A Molino; M Mormile; A Stanziola; I Scaricabarozzi; L Carratù
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure.

Authors:  E F Christensen; R Dahl
Journal:  Lung       Date:  1991       Impact factor: 2.584

10.  Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.

Authors:  J Tamaoki; A Chiyotani; E Tagaya; N Sakai; K Konno
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.